MyFinsight
Home
Blog
About
Back
Cash Flow
Xenetic Biosciences, Inc. (XBIO)
Xenetic Biosciences, Inc. (XBIO)
source: myfinsight.com
Net change in cash
-$875,489
(36.82%↑ Y/Y)
Prepaid expenses and
other
-$65,504
(-143.12%↓ Y/Y)
Share-based expense
$51,964
(48.75%↑ Y/Y)
Net cash used in
operating activities
-$875,489
(36.82%↑ Y/Y)
Canceled cashflow
$117,468
Net loss
-$929,695
(41.60%↑ Y/Y)
Accounts payable,
accrued expenses and...
-$63,262
(-790.11%↓ Y/Y)
Back